Thursday, October 31, 2024

Thursday, October 31, 2024

Organization Directory

Refine Your Search Community Associations G

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
  2. 2 TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)
FDA Health News